NIH: Company influenced sepsis treatment
(AP)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20061018/ap_on_he_me/drug_controversy"><img src="http://d.yimg.com/us.yimg.com/p/ap/20061017/capt.bd3496ba1f5340ceacbf4a7e6c20fbb0.lilly_icos_nybz106.jpg?x=130&y=100&sig=jvBkTm70TVwASS0Ce6f5Zg--" align="left" height="100" width="130" alt="A women leaves the Eli Lilly and Company campus in an Indianapolis file photo from April 18, 2006. Eli Lilly and Co. will buy joint venture partner Icos Corp. for $2.1 billion cash in a move to get full ownership of the venture's top-selling impotence treatment, Cialis. (AP Photo/Michael Conroy, File)" border="0" /></a>AP - Several government doctors say drug maker Eli Lilly & Co. subtly orchestrated medical guidelines for treatment of an often-lethal blood infection, hoping to boost sales of a drug whose value is being debated.</p><br clear="all"/>